<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:department>Psychosis Studies</gtr:department><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/7EA89E73-0C9C-4B42-A6B9-2A28BFC44DDE"><gtr:id>7EA89E73-0C9C-4B42-A6B9-2A28BFC44DDE</gtr:id><gtr:firstName>Rashmi</gtr:firstName><gtr:surname>Patel</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MR%2FK002813%2F1"><gtr:id>609371B4-B250-4C3C-BD95-65FACB29207F</gtr:id><gtr:title>Predicting clinical and functional outcomes in psychosis using machine learning</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>MR/K002813/1</gtr:grantReference><gtr:abstractText>Psychotic disorders affect around 3% of the UK population. People with psychotic disorders have enormous difficulties with social functioning, and most are unable to work. This leads to great suffering for those affected and their families, and a considerable economic cost to the NHS and society: an estimated &amp;pound;6.7 billion in the UK in 2004/5.

While there are treatments available for psychotic disorders (including medication and talking therapies), investigations still play no part in their diagnosis, and there are no tests which will predict which treatments are likely to be the best for each individual. It is also not possible to predict the outcomes of illness or how it may affect a person's life in the longer term. For these reasons, there is a great need to improve our understanding of the causes of psychosis and develop better ways of predicting outcomes to implement treatment strategies which are directly tailored towards individuals.

Current research suggests that a range of different genetic and environmental factors may be involved in causing psychotic disorders. It is thought that over a period of several years, these factors adversely affect the structure and function of the brain. Recent studies using MRI brain scans have shown abnormalities in certain areas of brain structure and function which are associated with psychotic disorders. However, while it is possible to detect these changes at a group level, it has so far been difficult to generalise these findings and apply them directly to affected individuals. One reason for this may be the level of complexity of interactions between the various factors which affect brain structure and function. Another difficulty is that the nature of psychotic illness varies widely between affected individuals, and our current methods of classifying psychotic disorders (which involves making a diagnosis based on clusters of symptoms according to predefined categories) may not accurately reflect the underlying cause of illness.

This research project (based in the Department of Psychosis Studies, King's College London) aims to investigate whether it is possible to develop a better classification of psychotic disorders which is based on a range of clinical and functional outcomes (e.g. psychotic symptoms, cognitive functioning, mood symptoms and social and occupational functioning) and to see if techniques may be developed to reliably predict the likelihood of these outcomes in individuals suffering with psychotic illness.

In order to achieve this, data from an anonymised case register (CRIS - South London and Maudsley NHS Foundation Trust) will be analysed to try to develop a method to characterise clinical and functional outcomes in patients with psychotic illness. In addition, machine learning will be used in an attempt to make predictions on outcomes using an existing dataset (including MRI brain scan analysis) from patients with psychosis. Machine learning is a technique in which information from a small dataset (where the outcome is known) is analysed to create an algorithm which can be used to make predictions on outcome at the level of an individual rather than an average for a group of individuals. A wide range of information can be analysed to make predictions including data from brain scans, clinical indicators and demographic data.

If successful, it is hoped that this research will help to improve our understanding of the nature and causes of psychotic disorders. In addition, prediction algorithms for various outcome measures generated from this project could subsequently be tested with newly collected data with the aim of eventually employing them as tools in clinical practice to develop more effective and personalised treatment strategies.</gtr:abstractText><gtr:technicalSummary>Background

Psychotic disorders are responsible for an enormous burden of illness upon individuals and society as a whole (Perala 2007). Structural, functional and DTI MRI studies have shown that the onset of psychosis is associated with changes in brain structure and function (Smieskova 2010 and Pettersson-Yeo 2011). However, it has been difficult to apply such group level findings to a clinical population at the level of the affected individual. This may reflect the overlapping genetic, neurobiological and clinical features of current diagnostic classification systems, which cannot reliably predict the course and outcome of psychotic disorders (Van Os 1997).

Aims

My project aims to analyse clinical and neuroimaging data of patients with psychotic disorders using Support Vector Machine learning (SVM) and Machine Kernel Learning (MKL) in order to generate more robust systems for classifying illness and predicting outcomes at the level of the affected individual.

Methods

(i) SVM analysis of data of patients with psychosis from a large, prospective case register (CRIS) to characterise clinical and functional outcomes and predict these with baseline clinical data at first episode.
(ii) Individual SVM analysis of clinical data, structural MRI, DTI and fMRI of patients with first episode psychosis to predict the same outcomes.
(iii) Analysis of clinical and neuroimaging data using MKL to investigate if combining modalities increases predictive power.

Implications

Prediction algorithms generated from this project will be further validated using a prospective dataset with the aim of subsequently evaluating successful algorithms in clinical studies. Generating reliable algorithms for predicting outcomes in psychosis may help to develop more effective and personalised treatments.</gtr:technicalSummary><gtr:potentialImpactText>The aim of the proposed project is to work towards developing prediction tools which will improve the clinical care of individuals with psychotic disorders. Psychotic disorders place a heavy burden of suffering on affected individuals and their families, as well as economic and social burdens on society as a whole. The MRC has identified research into mental health as a key priority. In particular, there is a need to conduct high quality translational research to develop more effective and more personalised treatment strategies for mental illness, as well as a greater focus on prevention. A key component of achieving this depends on being able to predict outcomes in each individual with psychosis. Beneficiaries of this work include:

(i) Patients: current treatment strategies for patients who experience a psychotic episode are reactive (rather than preventative) and often delayed. This is due to not recognising illness sooner and because trials of first line treatment are not always suitable for each individual patient. By developing better tools for predicting clinical outcomes, it might be possible to better target therapy at an earlier stage (thereby improving outcomes), and develop treatments for patients as individuals, rather than relying on generic treatment strategies.

(ii) Patients' relatives: the ability to better predict the nature and progression of illness will provide more accurate information on prognosis to the patient and their family, which will allow them to better plan for their involvement in the longer term.

(iii) Clinicians: this project will produce work that can be used to develop risk prediction tools which allow healthcare staff to employ more effective, individualised treatment plans and provide better information to patients about the outcomes of illness and treatment.

(iv) Mental health services: by developing tools for predicting outcomes in psychotic illness, it may be possible to better allocate resources within mental health services by ensuring that clinical expertise, social and community support are more efficiently targeted to the patients who are likely to need it, thereby improving the cost effectiveness of such interventions and reducing the opportunity cost from the use of generic treatment strategies which only benefit a proportion of patients.

(v) Health policy makers: as well as providing better predictive information at an individual level, obtaining reliable predictive information on outcomes of psychosis at a population level would allow health policy makers to better plan resource allocation and commissioning within the National Health Service. The use of objective patient data in predicting outcomes would also facilitate better audit of health service performance and ensure that individual health services deliver the most effective clinical care for their target populations.

Timescale: a range of machine learning algorithms for predicting different outcomes in psychosis will be developed during the research training fellowship which may then be tested in a prospective dataset at post-doctoral level. If successful, diagnostic and therapeutic interventional studies could subsequently be planned with the aim of subsequently bringing the benefits of this research to the beneficiaries outlined above.</gtr:potentialImpactText><gtr:fund><gtr:end>2016-01-13</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2013-01-14</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>174832</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>600</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Travel Grant</gtr:description><gtr:end>2016-10-02</gtr:end><gtr:fundingOrg>Guarantors of Brain</gtr:fundingOrg><gtr:id>3953E62E-4520-4AFE-8CF6-97A65DFD5092</gtr:id><gtr:outcomeId>586916e5e16d01.53816825</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Academy of Medical Sciences Starter Grant for Clinical Lecturers</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>Academy of Medical Sciences (AMS)</gtr:fundingOrg><gtr:fundingRef>SGL015/1020</gtr:fundingRef><gtr:id>49CA077E-F95F-422B-B50E-B5BC16AB5DD6</gtr:id><gtr:outcomeId>586914d96de781.22272477</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Contribution to commissioning of mental health service</gtr:description><gtr:geographicReach>Local/Municipal/Regional</gtr:geographicReach><gtr:id>0BA5A2B4-C6F9-4734-9A5E-5F89F343E059</gtr:id><gtr:impact>NICE Guidelines for the management of adults with psychosis (CG178) recommend that people with a decline in social functioning and attenuated psychotic symptoms or a first degree relative with psychosis should be referred to a specialist service for people at risk of psychosis. Despite this recommendation, few services for people at high risk of psychosis are available in the NHS.

Around a third of people referred to high risk services are already experiencing a first episode of psychosis (FEP). I have conducted a research study to investigate whether there are any differences in clinical outcomes between these patients compared to other mental health services. After adjusting for potentially confounding variables, I found that those who presented to the high risk service had fewer hospital admissions and spent less time in hospital compared to those who presented to other clinical services.

Prior to my study, there was no available evidence on the outcomes of people with FEP who present to high risk services. I have presented my findings locally and at two international conferences (IEPA and ICOSR). The results of my study have since been published (http://dx.doi.org/10.1111/acps.12480). They have also contributed towards a successful bid to King's Health Partners (an Academic Health Sciences Centre) and Clinical Commissioning Groups in South London to extend the current high risk service OASIS (http://oasis.london), which is already available in the boroughs of Lambeth and Southwark, to Lewisham and Croydon allowing more people to benefit from this clinical service.</gtr:impact><gtr:outcomeId>589473b9d19587.04762966</gtr:outcomeId><gtr:type>Implementation circular/rapid advice/letter to e.g. Ministry of Health</gtr:type><gtr:url>http://oasis.london</gtr:url></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs><gtr:softwareAndTechnicalProductOutput><gtr:description>TextHunter - A User Friendly Tool for Extracting Generic Concepts from Free Text in Clinical Research
Richard Jackson, Michael Ball, Rashmi Patel, Richard Hayes, Richard Dobson and Robert Stewart
Proceedings of AMIA, Nov 2014; 729-738.

TextHunter is a graphical user interface for the General Architecture for Text Engineering framework (GATE), a tool for developing natural language processing (NLP) applications to automatically extract information from unstructured free text documents. I contributed to software development by piloting it on a number of research studies whose aims were to develop NLP applications to automatically extract psychotic symptomatology and cannabis exposure in the anonymised electronic health records of people with psychotic disorders.</gtr:description><gtr:id>64BF4EB2-2752-4909-8205-54A5259AC7EC</gtr:id><gtr:impact>The software has contributed to a number of peer-reviewed publications:

http://dx.doi.org/10.1136/bmjopen-2015-007619

http://dx.doi.org/10.1136/bmjopen-2014-007504

https://kclpure.kcl.ac.uk/portal/en/publications/texthunter--a-user-friendly-tool-for-extracting-generic-concepts-from-free-text-in-clinical-research(a6399aef-e020-4466-804b-fb74ac1a9bb9).html

http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)60394-4/

https://kclpure.kcl.ac.uk/portal/en/publications/association-of-cannabis-use-with-hospital-admission-and-treatment-resistance-in-people-with-first-episode-psychosis-in-south-london(5db7d7db-5942-4f77-a4bf-73d552319902).html

http://www.sciencedirect.com/science/article/pii/S0920996414704499

http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(14)60279-8/</gtr:impact><gtr:outcomeId>5656f5a410c4c1.58726304</gtr:outcomeId><gtr:title>TextHunter</gtr:title><gtr:type>Software</gtr:type><gtr:url>http://dx.doi.org/10.5281/zenodo.11122</gtr:url><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput></gtr:softwareAndTechnicalProductOutputs><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>927E7E34-0EAF-4DBE-AD26-E7DCB664F323</gtr:id><gtr:title>Improving life expectancy in people with serious mental illness: should we place more emphasis on primary prevention?</gtr:title><gtr:parentPublicationTitle>The British journal of psychiatry : the journal of mental science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81c1e54c94fa4bdbc1edf12e71ad74ef"><gtr:id>81c1e54c94fa4bdbc1edf12e71ad74ef</gtr:id><gtr:otherNames>Ilyas A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0007-1250</gtr:issn><gtr:outcomeId>59d202581e2599.19417581</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>95E35B5B-2145-4E0E-80D3-EC246AD30AF8</gtr:id><gtr:title>A retrospective cohort study of 21,012 adults to investigate which antidepressants pose the greatest risk of developing mania</gtr:title><gtr:parentPublicationTitle>Early Intervention in Psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cc585c9cbeb7090bf64b237af957110c"><gtr:id>cc585c9cbeb7090bf64b237af957110c</gtr:id><gtr:otherNames>Rashmi Patel</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58691b1dbc8c28.76623642</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB20B60B-81E1-4A36-90F2-E0A3BB802DD1</gtr:id><gtr:title>Investigating clinical outcomes in psychotic disorders using an electronic case register</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/944e642d2d08cdc60ec7d9a9cacc81bd"><gtr:id>944e642d2d08cdc60ec7d9a9cacc81bd</gtr:id><gtr:otherNames>Patel Rashmi</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>5aae65f6c74d88.35368320</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>89DEF30C-3588-4838-B170-86E9530443A5</gtr:id><gtr:title>Clinical outcomes and mortality associated with weekend admission to psychiatric hospital: implications for provision of 7 day mental health care in the National Health Service</gtr:title><gtr:parentPublicationTitle>The Lancet</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10db95fd56b961dd90153cd3acb87a32"><gtr:id>10db95fd56b961dd90153cd3acb87a32</gtr:id><gtr:otherNames>Patel R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>56cee0e2d44885.45158277</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD2F2E6F-B948-45B6-8FAA-9DA2D02AA9C1</gtr:id><gtr:title>The Association Between Comorbid Autism Spectrum Disorders and Antipsychotic Treatment Failure in Early-Onset Psychosis: A Historical Cohort Study Using Electronic Health Records.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6c02740cd669ce4fdddb99a67b251842"><gtr:id>6c02740cd669ce4fdddb99a67b251842</gtr:id><gtr:otherNames>Downs JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0160-6689</gtr:issn><gtr:outcomeId>5a030af9a53ee0.18143942</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5DBA0A95-AC9A-4D22-8A37-A964E7B4D3AA</gtr:id><gtr:title>Venous thromboembolism prophylaxis - beware of potential risks</gtr:title><gtr:parentPublicationTitle>The Psychiatrist</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10db95fd56b961dd90153cd3acb87a32"><gtr:id>10db95fd56b961dd90153cd3acb87a32</gtr:id><gtr:otherNames>Patel R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:outcomeId>54590c127dac06.72128626</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1170B98-3986-457C-97A8-452AA174EAD6</gtr:id><gtr:title>Impact of cannabis use on clinical outcomes and treatment failure in first episode psychosis</gtr:title><gtr:parentPublicationTitle>npj Schizophrenia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d1b8605c33f288f7841f296b835c7c7"><gtr:id>1d1b8605c33f288f7841f296b835c7c7</gtr:id><gtr:otherNames>Patel, R.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>570ffbc36bd252.25465388</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>98D47962-C95B-43C3-8AF4-6A68115297F1</gtr:id><gtr:title>Investigation of negative symptoms in schizophrenia with a machine learning text-mining approach</gtr:title><gtr:parentPublicationTitle>The Lancet</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10db95fd56b961dd90153cd3acb87a32"><gtr:id>10db95fd56b961dd90153cd3acb87a32</gtr:id><gtr:otherNames>Patel R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>54590c12aa26c9.60542939</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>233080A4-FDBB-445F-9235-5E40F464D323</gtr:id><gtr:title>Mood instability is a common feature of mental health disorders and is associated with poor clinical outcomes.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10db95fd56b961dd90153cd3acb87a32"><gtr:id>10db95fd56b961dd90153cd3acb87a32</gtr:id><gtr:otherNames>Patel R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>555efa82742287.40250833</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AD7ACDCA-D1F6-4111-B877-100E2EE1E6B0</gtr:id><gtr:title>Cannabis use and treatment resistance in first episode psychosis: a natural language processing study</gtr:title><gtr:parentPublicationTitle>The Lancet</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10db95fd56b961dd90153cd3acb87a32"><gtr:id>10db95fd56b961dd90153cd3acb87a32</gtr:id><gtr:otherNames>Patel R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>54f06410cb29e1.86664018</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E00CD52B-9450-43A4-A376-B8620288748A</gtr:id><gtr:title>P.3.004 Association of antidepressant therapy with onset of mania</gtr:title><gtr:parentPublicationTitle>European Neuropsychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10db95fd56b961dd90153cd3acb87a32"><gtr:id>10db95fd56b961dd90153cd3acb87a32</gtr:id><gtr:otherNames>Patel R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>54590c12cec0b7.06382638</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5867A4CD-2CDB-433E-8C28-0A93C6E00103</gtr:id><gtr:title>A neuroplastic deafferentation hypothesis for bipolar disorder.</gtr:title><gtr:parentPublicationTitle>Medical hypotheses</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3319186e5b2b78afe0a4c18dac384546"><gtr:id>3319186e5b2b78afe0a4c18dac384546</gtr:id><gtr:otherNames>Rogers J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0306-9877</gtr:issn><gtr:outcomeId>5627fc6557d979.59151953</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>600C393F-B376-4E86-8369-7C36DF4B7907</gtr:id><gtr:title>Mood instability and clinical outcomes in mental health disorders: A natural language processing (NLP) study</gtr:title><gtr:parentPublicationTitle>European Psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10db95fd56b961dd90153cd3acb87a32"><gtr:id>10db95fd56b961dd90153cd3acb87a32</gtr:id><gtr:otherNames>Patel R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>570ffb6cb4c5e2.91542231</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5DC1845B-DE7B-42ED-8E7E-078F90E96CCD</gtr:id><gtr:title>Natural language processing to extract symptoms of severe mental illness from clinical text: the Clinical Record Interactive Search Comprehensive Data Extraction (CRIS-CODE) project.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b4915fb9d77aa568dbc5a9ff65fa31a"><gtr:id>6b4915fb9d77aa568dbc5a9ff65fa31a</gtr:id><gtr:otherNames>Jackson RG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>587f40da3e2c84.66011484</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ACC38B2F-79C2-419B-8E8A-656062EBB7F1</gtr:id><gtr:title>Negative symptoms in schizophrenia: a study in a large clinical sample of patients using a novel automated method.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10db95fd56b961dd90153cd3acb87a32"><gtr:id>10db95fd56b961dd90153cd3acb87a32</gtr:id><gtr:otherNames>Patel R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>55eeb032a94398.20791441</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B67B9B8F-93B9-4FB3-9692-8713CB9161B4</gtr:id><gtr:title>Delays to diagnosis and treatment in patients presenting to mental health services with bipolar disorder</gtr:title><gtr:parentPublicationTitle>European Psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10db95fd56b961dd90153cd3acb87a32"><gtr:id>10db95fd56b961dd90153cd3acb87a32</gtr:id><gtr:otherNames>Patel R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>570ffaad1e93d6.71622142</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F77EE9A6-56BD-4C7B-9FE9-2D9FD8A2B135</gtr:id><gtr:title>Do fewer males present to clinical high-risk services for psychosis relative to first-episode services?</gtr:title><gtr:parentPublicationTitle>Early intervention in psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4bb42d39c387ce1f1b78fcda938784b8"><gtr:id>4bb42d39c387ce1f1b78fcda938784b8</gtr:id><gtr:otherNames>Wilson RP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1751-7885</gtr:issn><gtr:outcomeId>56b0b536c07694.22580160</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6FE9B645-4450-462A-9F3A-21A1691B8A9D</gtr:id><gtr:title>Investigating Mood Instability in Psychotic Disorders Using Natural Language Processing (NLP)</gtr:title><gtr:parentPublicationTitle>Early Intervention in Psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cc585c9cbeb7090bf64b237af957110c"><gtr:id>cc585c9cbeb7090bf64b237af957110c</gtr:id><gtr:otherNames>Rashmi Patel</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58691b748585b6.05368631</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6093C2A-8DC9-4F18-A6ED-985865CCABA8</gtr:id><gtr:title>Which antidepressants are associated with increased risk of developing mania? A retrospective electronic case register cohort study</gtr:title><gtr:parentPublicationTitle>European Psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10db95fd56b961dd90153cd3acb87a32"><gtr:id>10db95fd56b961dd90153cd3acb87a32</gtr:id><gtr:otherNames>Patel R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>570ffb25a1c0d0.28954557</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>69DB8F2D-1A81-4CF7-B705-7BB26E37F2F2</gtr:id><gtr:title>Negative Symptoms in Early-Onset Psychosis and Their Association With Antipsychotic Treatment Failure.</gtr:title><gtr:parentPublicationTitle>Schizophrenia bulletin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eb90a833dbe37ce12de107ab7a5f2964"><gtr:id>eb90a833dbe37ce12de107ab7a5f2964</gtr:id><gtr:otherNames>Downs J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0586-7614</gtr:issn><gtr:outcomeId>5a69e30a04fce7.60249169</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>846C8EFE-9658-4C26-99F7-B504D518046F</gtr:id><gtr:title>Predictors of multiple treatment failure of antipsychotics in early-onset psychosis</gtr:title><gtr:parentPublicationTitle>European Neuropsychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f022cc1d5e3600934e0c0bd9566836d"><gtr:id>8f022cc1d5e3600934e0c0bd9566836d</gtr:id><gtr:otherNames>Pina-Camacho L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>5869195da2cb53.32091288</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FFAC3919-2535-44F1-9B50-ADA66A1F8CC8</gtr:id><gtr:title>The Camden &amp;amp; Islington Research Database: Using electronic mental health records for research.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4159ebddce1cbcfc090dfac581a434d9"><gtr:id>4159ebddce1cbcfc090dfac581a434d9</gtr:id><gtr:otherNames>Werbeloff N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5a71cf147fe744.10991280</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A8EF3202-EC5C-4DB9-9632-A73A0C5215C5</gtr:id><gtr:title>Venous thromboembolism prophylaxis in mental healthcare: do the benefits outweigh the risks?</gtr:title><gtr:parentPublicationTitle>BJPsych bulletin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10db95fd56b961dd90153cd3acb87a32"><gtr:id>10db95fd56b961dd90153cd3acb87a32</gtr:id><gtr:otherNames>Patel R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2056-4694</gtr:issn><gtr:outcomeId>54590d0f7a5440.01980854</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB72E9F2-4760-40FD-AA35-FB166ABA65C4</gtr:id><gtr:title>Poster #S170 IDENTIFYING NEGATIVE SYMPTOMS IN SCHIZOPHRENIA AND ASSOCIATION WITH CLINICAL OUTCOMES USING NATURAL LANGUAGE PROCESSING</gtr:title><gtr:parentPublicationTitle>Schizophrenia Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10db95fd56b961dd90153cd3acb87a32"><gtr:id>10db95fd56b961dd90153cd3acb87a32</gtr:id><gtr:otherNames>Patel R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>54590c12f341f5.57277437</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>84089FD0-DC11-49C2-BB4D-137B42374827</gtr:id><gtr:title>Association of cannabis use with hospital admission and antipsychotic treatment failure in first episode psychosis: an observational study.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10db95fd56b961dd90153cd3acb87a32"><gtr:id>10db95fd56b961dd90153cd3acb87a32</gtr:id><gtr:otherNames>Patel R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>56d93a70cf8cd4.72198563</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78996F2F-DF3B-4BD8-8074-77F02377F34F</gtr:id><gtr:title>What proportion of patients with psychosis is willing to take part in research? A mental health electronic case register analysis.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10db95fd56b961dd90153cd3acb87a32"><gtr:id>10db95fd56b961dd90153cd3acb87a32</gtr:id><gtr:otherNames>Patel R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>58c254a5a454e2.26482316</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DD296310-A4A5-47DA-A2A6-87EAC0379833</gtr:id><gtr:title>Clinical outcomes and mortality associated with weekend admission to psychiatric hospital.</gtr:title><gtr:parentPublicationTitle>The British journal of psychiatry : the journal of mental science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10db95fd56b961dd90153cd3acb87a32"><gtr:id>10db95fd56b961dd90153cd3acb87a32</gtr:id><gtr:otherNames>Patel R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0007-1250</gtr:issn><gtr:outcomeId>5718a6048e5609.12329795</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B03D952-4748-413D-917F-B0DFC8093E9F</gtr:id><gtr:title>Predicting clinical outcomes in psychotic disorders using electronic case registers and natural language processing</gtr:title><gtr:parentPublicationTitle>npj Schizophrenia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d1b8605c33f288f7841f296b835c7c7"><gtr:id>1d1b8605c33f288f7841f296b835c7c7</gtr:id><gtr:otherNames>Patel, R.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>570ffbff6c71e2.08585699</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D2EFE227-02E8-4477-951F-79BB0DA80325</gtr:id><gtr:title>Services for people at high risk improve outcomes in patients with first episode psychosis.</gtr:title><gtr:parentPublicationTitle>Acta psychiatrica Scandinavica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d291d20ff6b7d57155002e6583fb3ce2"><gtr:id>d291d20ff6b7d57155002e6583fb3ce2</gtr:id><gtr:otherNames>Fusar-Poli P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0001-690X</gtr:issn><gtr:outcomeId>55f2d8eb34d0c7.47854690</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C8B36AB-0E4C-45AA-ADBC-1B29F34557E4</gtr:id><gtr:title>Delays before Diagnosis and Initiation of Treatment in Patients Presenting to Mental Health Services with Bipolar Disorder.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10db95fd56b961dd90153cd3acb87a32"><gtr:id>10db95fd56b961dd90153cd3acb87a32</gtr:id><gtr:otherNames>Patel R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>555cdf6a08d6e7.04356514</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>737403C7-0B43-4115-83DD-A7EF80128597</gtr:id><gtr:title>Do antidepressants increase the risk of mania and bipolar disorder in people with depression? A retrospective electronic case register cohort study.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10db95fd56b961dd90153cd3acb87a32"><gtr:id>10db95fd56b961dd90153cd3acb87a32</gtr:id><gtr:otherNames>Patel R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>566ff2c7843460.20883110</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0779F462-4211-4F9B-A17F-C31CF1E15EF3</gtr:id><gtr:title>Neurobiological basis of motivational deficits in psychopathology.</gtr:title><gtr:parentPublicationTitle>European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d1b6c947b5355c1ed4b120dd018f8ffd"><gtr:id>d1b6c947b5355c1ed4b120dd018f8ffd</gtr:id><gtr:otherNames>Salamone JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0924-977X</gtr:issn><gtr:outcomeId>5675dd2a90cec</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>71481BC9-C491-411E-BC8A-498F2AE348E4</gtr:id><gtr:title>Is paliperidone palmitate more effective than other long-acting injectable antipsychotics?</gtr:title><gtr:parentPublicationTitle>Psychological medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10db95fd56b961dd90153cd3acb87a32"><gtr:id>10db95fd56b961dd90153cd3acb87a32</gtr:id><gtr:otherNames>Patel R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0033-2917</gtr:issn><gtr:outcomeId>59f70088a57067.35610066</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C9C83626-4DC4-47BF-9273-556CF344D317</gtr:id><gtr:title>Comparison of clinical outcomes associated with long-acting injectable antipsychotics in people with psychotic disorders: an electronic case register study</gtr:title><gtr:parentPublicationTitle>The Lancet</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10db95fd56b961dd90153cd3acb87a32"><gtr:id>10db95fd56b961dd90153cd3acb87a32</gtr:id><gtr:otherNames>Patel R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>58b416ef9cf060.83567194</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/K002813/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>3C193D18-12BD-4B15-8347-037BA623E0FF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Mental Health</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>89AE580F-2437-4540-9640-37005C968E67</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>4.1  Discovery and preclinical testing of markers and technologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>